ImmunoGen, Inc. EBITDA Margin 2010-2023 | IMGN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ImmunoGen, Inc. (IMGN) over the last 10 years. The current EBITDA margin for ImmunoGen, Inc. as of September 30, 2023 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-09-30 $0.29B $-0.08B -27.53%
2023-06-30 $0.19B $-0.18B -96.30%
2023-03-31 $0.12B $-0.24B -199.17%
2022-12-31 $0.11B $-0.22B -202.78%
2022-09-30 $0.10B $-0.19B -204.21%
2022-06-30 $0.09B $-0.15B -169.66%
2022-03-31 $0.09B $-0.12B -127.17%
2021-12-31 $0.07B $-0.12B -175.71%
2021-09-30 $0.13B $-0.05B -40.63%
2021-06-30 $0.14B $-0.03B -24.82%
2021-03-31 $0.14B $-0.03B -18.52%
2020-12-31 $0.13B $-0.02B -15.15%
2020-09-30 $0.09B $-0.05B -52.75%
2020-06-30 $0.09B $-0.05B -56.98%
2020-03-31 $0.09B $-0.07B -81.61%
2019-12-31 $0.08B $-0.09B -106.02%
2019-09-30 $0.05B $-0.14B -266.67%
2019-06-30 $0.05B $-0.16B -332.65%
2019-03-31 $0.04B $-0.16B -378.57%
2018-12-31 $0.05B $-0.15B -288.68%
2018-09-30 $0.08B $-0.12B -154.43%
2018-06-30 $0.08B $-0.11B -142.11%
2018-03-31 $0.11B $-0.08B -71.70%
2017-12-31 $0.11B $-0.05B -46.49%
2017-06-30 $0.08B $-0.05B -69.33%
2017-03-31 $0.04B $-0.08B -190.70%
2016-09-30 $0.05B $-0.08B -147.17%
2016-06-30 $0.06B $-0.07B -116.67%
2015-12-31 $0.04B $-0.03B -61.36%
2015-09-30 $0.07B $0.00B 5.41%
2014-12-31 $0.07B $-0.01B -8.82%
2014-09-30 $0.05B $-0.03B -50.00%
2013-12-31 $0.07B $0.02B 30.56%
2013-09-30 $0.05B $-0.01B -11.11%
2012-12-31 $0.01B $-0.04B -370.00%
2012-09-30 $0.02B $-0.03B -213.33%
2011-12-31 $0.02B $-0.02B -137.50%
2011-09-30 $0.01B $-0.03B -216.67%
2010-12-31 $0.01B $-0.02B -170.00%
2010-09-30 $0.01B $-0.02B -200.00%
2009-12-31 $0.01B $-0.01B -71.43%